NO142402C - Analogifremgangsmaate for fremstilling av farmakologisk aktive benzimidazoler - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive benzimidazoler

Info

Publication number
NO142402C
NO142402C NO752022A NO752022A NO142402C NO 142402 C NO142402 C NO 142402C NO 752022 A NO752022 A NO 752022A NO 752022 A NO752022 A NO 752022A NO 142402 C NO142402 C NO 142402C
Authority
NO
Norway
Prior art keywords
preparation
pharmacologically active
analogy procedure
benzimidazoles
active benzimidazoles
Prior art date
Application number
NO752022A
Other languages
English (en)
Norwegian (no)
Other versions
NO752022L (en, 2012
NO142402B (no
Inventor
Volkhard Austel
Eberhard Kutter
Joachim Heider
Wolfgang Eberlein
Rudolf Kadatz
Willi Diederen
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742427943 external-priority patent/DE2427943C2/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO752022L publication Critical patent/NO752022L/no
Publication of NO142402B publication Critical patent/NO142402B/no
Publication of NO142402C publication Critical patent/NO142402C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO752022A 1974-06-10 1975-06-09 Analogifremgangsmaate for fremstilling av farmakologisk aktive benzimidazoler NO142402C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19742427943 DE2427943C2 (de) 1974-06-10 1974-06-10 Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2516040A DE2516040C2 (de) 1974-06-10 1975-04-12 Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
NO752022L NO752022L (en, 2012) 1975-12-11
NO142402B NO142402B (no) 1980-05-05
NO142402C true NO142402C (no) 1980-08-13

Family

ID=25767253

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752022A NO142402C (no) 1974-06-10 1975-06-09 Analogifremgangsmaate for fremstilling av farmakologisk aktive benzimidazoler

Country Status (23)

Country Link
US (1) US4026891A (en, 2012)
JP (1) JPS6015632B2 (en, 2012)
AT (1) AT342610B (en, 2012)
BE (1) BE830030A (en, 2012)
BG (2) BG23216A3 (en, 2012)
CA (1) CA1041095A (en, 2012)
CH (1) CH620438A5 (en, 2012)
CS (1) CS195292B2 (en, 2012)
DD (1) DD120440A5 (en, 2012)
DE (1) DE2516040C2 (en, 2012)
DK (1) DK258975A (en, 2012)
ES (2) ES437296A1 (en, 2012)
FI (1) FI59408C (en, 2012)
FR (1) FR2273545A1 (en, 2012)
GB (1) GB1466547A (en, 2012)
HU (1) HU171059B (en, 2012)
IE (1) IE41257B1 (en, 2012)
IL (1) IL47445A (en, 2012)
NL (1) NL178969C (en, 2012)
NO (1) NO142402C (en, 2012)
PH (1) PH14298A (en, 2012)
RO (1) RO68750A (en, 2012)
SE (1) SE420836B (en, 2012)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53117215A (en) * 1977-03-24 1978-10-13 Hideyoshi Morita Earthquakeeproof steel beam
ES8101067A1 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
DE2935359A1 (de) * 1979-09-01 1981-03-26 Basf Ag, 67063 Ludwigshafen 6-imidazolyl-3-hydrazino-pyridazine
DE3006671A1 (de) * 1980-02-22 1981-08-27 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzoxazole, deren herstellung und deren verwendung als arzneumittel
DE3129447A1 (de) * 1981-07-25 1983-02-10 Dr. Karl Thomae Gmbh, 7950 Biberach "neue benztriazole, ihre herstellung und ihre verwendung als arzneimittel"
US4699909A (en) * 1981-07-25 1987-10-13 Dr. Karl Thomae Gmbh Benzotriazolyl-4,5-dihydro-3(2H)-pyridazinones
US4840955A (en) * 1984-12-24 1989-06-20 Warner-Lambert Company 6-substituted-2(1H)-quinolinones and related compounds having use as cardiotonic, antihypertensive, and antithrombotic agents
ZA859091B (en) * 1984-12-24 1987-07-29 Warner Lambert Co Novel 6-substituted-2 (1h)-quinolinones and related compounds having use as cardiotonic,anti-hypertensive,and anti-thrombotic agents
US4868300A (en) * 1985-11-22 1989-09-19 Rorer Pharmaceutical Corporation Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
US4725686A (en) * 1985-11-22 1988-02-16 William H. Rorer, Inc. Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4785101A (en) * 1985-11-22 1988-11-15 Rorer Pharmaceutical Corporation Benzodiazinone-hydroxypyrazolyl compounds, cardiotonic compositions including the same and their uses
US4859672A (en) * 1986-10-29 1989-08-22 Rorer Pharmaceutical Corporation Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
US5002944A (en) * 1986-10-29 1991-03-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cardiotonic activity
JPS63181827U (en, 2012) * 1987-05-13 1988-11-24
DE4237656A1 (de) * 1992-06-13 1993-12-16 Merck Patent Gmbh Benzimidazolderivate
US6465484B1 (en) 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
US6162804A (en) * 1997-09-26 2000-12-19 Merck & Co., Inc. Tyrosine kinase inhibitors
US6710046B1 (en) * 1998-10-23 2004-03-23 Toray Industries, Inc. Pharmaceutical composition for modulating immunity
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
BRPI0515505A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
MX2007003321A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
WO2006034441A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1804792A1 (en) * 2004-09-20 2007-07-11 Xenon Pharmaceuticals Inc. Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd)
CA2580857A1 (en) * 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
JP5149009B2 (ja) 2004-09-20 2013-02-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリダジン誘導体
JP4714921B2 (ja) * 2005-02-14 2011-07-06 トーアエイヨー株式会社 ピモベンダンの製造法及びその中間体
US8541457B2 (en) * 2005-06-03 2013-09-24 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
RU2499795C2 (ru) * 2005-07-04 2013-11-27 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
JP5175730B2 (ja) * 2005-08-15 2013-04-03 アイアールエム・リミテッド・ライアビリティ・カンパニー Ｔｐｏ模倣剤としての化合物および組成物
DK2079732T3 (da) * 2006-05-29 2012-01-23 High Point Pharmaceuticals Llc 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazin, dets salte og solvater og dets anvendelse som histamin H3-receptorantagonister
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
AR075858A1 (es) 2009-03-18 2011-05-04 Schering Corp Compuestos biciclicos como inhibidores de diacilglicerol aciltransferasa
US8729263B2 (en) 2012-08-13 2014-05-20 Novartis Ag 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
JP6461150B2 (ja) * 2013-07-31 2019-01-30 ノバルティス アーゲー １，４−二置換ピリダジン誘導体およびｓｍｎ欠損に関連する状態を処置するためのその使用
WO2018086703A1 (en) * 2016-11-11 2018-05-17 Bayer Pharma Aktiengesellschaft Dihydropyridazinones substituted with phenylureas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL23847A (en) * 1964-08-07 1969-02-27 Merck & Co Inc Benzimidazoles useful as antifungals
US3705157A (en) * 1970-10-19 1972-12-05 American Cyanamid Co Azolylpyridazine compounds and quaternary salts thereof
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US3969526A (en) * 1973-05-29 1976-07-13 Smithkline Corporation Anthelmintic 5-heterocycliothio and oxy-2-carbalkoxyaminobenzimidazles

Also Published As

Publication number Publication date
HU171059B (hu) 1977-10-28
NL7506806A (nl) 1975-12-12
DK258975A (da) 1975-12-11
IE41257L (en) 1975-12-10
FI751700A7 (en, 2012) 1975-12-11
NL178969C (nl) 1986-06-16
CS195292B2 (en) 1980-01-31
AT342610B (de) 1978-04-10
SE7506583L (sv) 1975-12-11
BE830030A (fr) 1975-12-09
BG24052A3 (bg) 1977-12-15
ATA344575A (de) 1977-08-15
DD120440A5 (en, 2012) 1976-06-12
JPS516980A (en, 2012) 1976-01-20
FR2273545A1 (fr) 1976-01-02
BG23216A3 (bg) 1977-07-12
SE420836B (sv) 1981-11-02
IL47445A0 (en) 1975-08-31
IL47445A (en) 1978-07-31
GB1466547A (en) 1977-03-09
NO752022L (en, 2012) 1975-12-11
ES441340A1 (es) 1977-03-16
NO142402B (no) 1980-05-05
RO68750A (ro) 1980-03-15
DE2516040C2 (de) 1984-12-20
CH620438A5 (en, 2012) 1980-11-28
AU8192675A (en) 1976-12-16
DE2516040A1 (de) 1976-11-04
FR2273545B1 (en, 2012) 1979-08-10
FI59408C (fi) 1981-08-10
FI59408B (fi) 1981-04-30
JPS6015632B2 (ja) 1985-04-20
PH14298A (en) 1981-05-19
US4026891A (en) 1977-05-31
CA1041095A (en) 1978-10-24
IE41257B1 (en) 1979-11-21
ES437296A1 (es) 1977-01-01

Similar Documents

Publication Publication Date Title
NO142402C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzimidazoler
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO143942C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive heterocyklisk substituerte guanidiner
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
SE431544B (sv) Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat
NO143315C (no) Analogifremgangsmaate ved fremstilling av farmakologisk aktive bis-imidazol-derivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO141207C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO149388C (no) Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO142403C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner.
NO144704C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater